<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id>
      <journal-title>BMC Cancer</journal-title>
      <issn pub-type="epub">1471-2407</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">15575962</article-id>
      <article-id pub-id-type="pmc">539302</article-id>
      <article-id pub-id-type="publisher-id">1471-2407-4-90</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2407-4-90</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Penile metastasis from primary transitional cell carcinoma of the renal pelvis: first manifestation of systemic spread</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Pomara</surname>
            <given-names>Giorgio</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>g.pomara@libero.it</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Pastina</surname>
            <given-names>Ilaria</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>g.pomara@libero.it</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Simone</surname>
            <given-names>Maurizio</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>m_simone@virgilio.it</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Casale</surname>
            <given-names>Paolo</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>g.pomara@libero.it</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Marchetti</surname>
            <given-names>Gabriella</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>g.pomara@libero.it</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Francesca</surname>
            <given-names>Francesco</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>f.francesca@ao-pisa.toscana.it</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Surgery, Urology Unit, S. Chiara Hospital, Pisa, Italy</aff>
      <aff id="I2"><label>2</label>Department of Oncology, S. Chiara Hospital, Pisa, Italy</aff>
      <aff id="I3"><label>3</label>Department of Pathological Anatomy, S. Chiara Hospital, Pisa, Italy</aff>
      <pub-date pub-type="collection">
        <year>2004</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>12</month>
        <year>2004</year>
      </pub-date>
      <volume>4</volume>
      <fpage>90</fpage>
      <lpage>90</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/4/90"/>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>6</month>
          <year>2004</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>12</month>
          <year>2004</year>
        </date>
      </history>
      <copyright-statement>Copyright &#xA9; 2004 Pomara et al; licensee BioMed Central Ltd.</copyright-statement>
      <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
        <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
      </license>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Almost one-third of all penile metastases are detected at the same time as a primary tumor, whereas the remaining two-thirds are detected a mean of 18 months after the discovery of the primary tumor. Cutaneous metastasis of transitional cell carcinoma (TCC) is extremely rare and generally accepted as the late manifestation of a systemic spread.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report the first case of simultaneous penile and lung metastases from a primary TCC of the renal pelvis in a 76-year-old man, that occurred 8 years after a left nephroureterectomy.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This case report underscores the importance of physical examinations of the skin of patients who undergo surgical procedures for TCC from bladder as well as from the upper urinary tract, including those seemingly without metastatic disease, because of the possibility of skin and penile metastatic spread.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Approximately 300 cases of penile metastases are reported worldwide [<xref ref-type="bibr" rid="B1">1</xref>]. Seventy percent of these metastases have their origin in the genitourinary tract, and the primary tumor is most frequently located in the bladder [<xref ref-type="bibr" rid="B2">2</xref>]. We present the first case of penile metastasis from primary transitional cell carcinoma (TCC) of the renal pelvis, and discuss the striking feature of discovering lung metastasis almost simultaneously.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 76-year-old man with a painful, ulcerative swelling of the glans that had appeared less than 2 months previously was brought to our attention. Physical examination revealed a 3.5-cm fungating lesion involving the upper half of the glans [Fig. <xref ref-type="fig" rid="F1">1</xref>]. The lesion was malodorous with varying amounts of seropurulent discharge, partially ulcerated, erythematous, and slightly itchy. The superficial inguinal lymph nodes were not palpable. No similar lesions were evident on the head, neck, trunk, or arms. The patient had been treated in another hospital 8 years previously for TCC of the left renal pelvis by nephroureterectomy (pT2 Nx M0 G2). Subsequent postoperative follow-ups (every 6 months for the first 3 years after surgery and then once every year) consisting of a clinical examination, total body CT scan, and regular endoscopic examination showed no evidence of recurrence and the patient did well until he noticed the painful penile nodule. Pathological examination of incisional biopsies confirmed the lesion to be urothelial carcinoma [Fig. <xref ref-type="fig" rid="F2">2</xref>]. A subsequent CT workup revealed a 4-cm lesion localized in the upper-right pulmonary lobe and enlarged pelvic lymph nodes suggestive of multiple metastases.</p>
      <p>The patient began combination chemotherapy (gemcitabine at 1250 mg/m2 on days 1, 8, and 15, and then every 28 days for six courses) and external beam radiotherapy to the mass, which promptly relieved the penile pain. At an 8-month follow-up the patient was still alive with no remarkable changes to the pulmonary and lymph node metastases, or the penile swelling.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Cutaneous metastases from primary TCC of the urinary system are extremely rare and are generally accepted as late manifestations of systemic spread [<xref ref-type="bibr" rid="B1">1</xref>]. Spector et al. (1987) suggested that skin metastases in TCC were the result of increased longevity in successfully treated patients [<xref ref-type="bibr" rid="B3">3</xref>]. Various mechanisms by which lesions may metastasize to the penis have been reported. Recently Bordeau and Lynch and Berger et al. reported three cases of penile metastases from TCC of the bladder in which they assumed that metastatic spread from primary bladder cancer to the penis occurred mainly via the retrograde venous route [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. There are also a few reports of TCC seeding outside the urinary tract after iatrogenic procedures (i.e., partial cystectomy, suprapubic cystostomy, pyelotomy, and laparoscopy) as the cause of cutaneous metastasis [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Between 5% and 20% of patients with superficial bladder cancer have vascular or lymphatic spread [<xref ref-type="bibr" rid="B5">5</xref>], and the reported rate of skin metastasis from TCC of the bladder is between 0.2% and 2% [<xref ref-type="bibr" rid="B7">7</xref>]. The rate of skin metastasis from TCC of the renal pelvis is currently unknown, and to the best of our knowledge ours is the first reported case of penile metastasis from TCC of the upper urinary tract.</p>
      <p>Almost one-third of all penile metastases are generally detected at the same time as a primary tumor, whereas the remaining two-thirds are detected a mean of 18 months after the discovery of the primary tumor [<xref ref-type="bibr" rid="B8">8</xref>]. Because the disease-free survival of this patient was 8 years following the diagnosis of the primary tumor, this case report represents a description of the biology of an unusual tumor. Moreover, the penile metastasis in this case was not the late manifestation of systemic spread, as is usually reported in the literature [<xref ref-type="bibr" rid="B1">1</xref>]; in fact, the patient was accurately evaluated with a standard follow-up scheme. Therefore, it is plausible that the lung metastasis appears almost simultaneously with the penile metastasis.</p>
      <p>The optimal treatment of penile metastasis requires a multidisciplinary approach that is correlated with the disease extent. The average survival in patients with penile metastasis is 3.9 months from diagnosis and, with extensive surgery and chemotherapy, a survival of 9.2 months has been reported [<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>This patient was not eligible for platinum-based regimens due to impaired renal function (prior nephrectomy) and advanced age. As a result, he was treated with gemcitabine as a single agent. This treatment has demonstrated objective response rates of 25&#x2013;29% with minimal toxicity as compared to standard regimens [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>].</p>
      <p>In conclusion, this case report suggests that particular attention should be paid to physical examination of the skin of patients who undergo surgical procedures for TCC from bladder as well as from the upper urinary tract, including those seemingly without metastatic disease, because of the possibility of skin and penile metastatic spread.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>GP drafted the manuscript and coordinated the co-authors. IP, MS, PC participated in the sequences alignment. GM carried out the histological features of the lesion. FF participated in the sequences alignment and coordinated the co-authors. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/4/90/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgement</title>
        <p>The patient gave his approval for publication.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akman</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Cam</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kavak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alper</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Extensive cutaneous metastasis of transitional cell carcinoma of the bladder</article-title>
          <source>Int J Urol</source>
          <year>2003</year>
          <volume>10</volume>
          <fpage>103</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">12588608</pub-id>
          <pub-id pub-id-type="doi">10.1046/j.1442-2042.2003.00571.x</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bordeau</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>DF</given-names>
            </name>
          </person-group>
          <article-title>Transitional cell carcinoma of the bladder metastatic to the penis</article-title>
          <source>Urology</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>981</fpage>
          <lpage>983</lpage>
          <pub-id pub-id-type="pmid">15134996</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.urology.2003.12.033</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spector</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Zimbler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>De Leo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Skin metastasis from transitional cell carcinoma</article-title>
          <source>Urology</source>
          <year>1987</year>
          <volume>29</volume>
          <fpage>215</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="pmid">3811102</pub-id>
          <pub-id pub-id-type="doi">10.1016/0090-4295(87)90159-2</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berger</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Rogatsch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hoeltl</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Steiner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bartsch</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hobisch</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Late penile metastasis from primary bladder carcinoma</article-title>
          <source>Urology</source>
          <year>2003</year>
          <volume>62</volume>
          <fpage>145</fpage>
          <pub-id pub-id-type="pmid">12837452</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0090-4295(03)00239-5</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ikehara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Akaeda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mihara</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous metastatic carcinoma of the penis:suspected metastasis implantation from a bladder tumor</article-title>
          <source>J Urol</source>
          <year>2000</year>
          <volume>163</volume>
          <fpage>1519</fpage>
          <pub-id pub-id-type="pmid">10751873</pub-id>
          <pub-id pub-id-type="doi">10.1097/00005392-200005000-00030</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andersen</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Steven</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Implantation metastasis after laparoscopic biopsy of bladder cancer</article-title>
          <source>J Urol</source>
          <year>1995</year>
          <volume>153</volume>
          <fpage>1047</fpage>
          <pub-id pub-id-type="pmid">7853557</pub-id>
          <pub-id pub-id-type="doi">10.1097/00005392-199503001-00038</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zirwas</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Logan</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Abernethy</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Seraly</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>A painful cutaneous nodule as the presentation of metastatic transitional cell carcinoma of the renal pelvis</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2000</year>
          <volume>42</volume>
          <fpage>867</fpage>
          <lpage>868</lpage>
          <pub-id pub-id-type="pmid">10767689</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0190-9622(00)90256-1</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maier</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Grimm</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Transitional cell carcinoma of the bladder with solitary metastasis to the penis 4 years after successful heart transplantation</article-title>
          <source>Transplantation</source>
          <year>1994</year>
          <volume>58</volume>
          <fpage>861</fpage>
          <lpage>863</lpage>
          <pub-id pub-id-type="pmid">7940726</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stadler</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Kuzel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Raghavan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dorr</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
          <article-title>Phase II studyof single-agent gemcitabine in previously untreted patients with metastatic urothelial cancer</article-title>
          <source>J Clin Oncol</source>
          <year>1997</year>
          <volume>15</volume>
          <fpage>3394</fpage>
          <lpage>3399</lpage>
          <pub-id pub-id-type="pmid">9363871</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lorusso</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pollera</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Antimi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Luporini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gridelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Frassineti</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Oliva</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pacini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>De Lena</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A phaseII study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum</article-title>
          <source>Eur J Cancer</source>
          <year>1998</year>
          <volume>34</volume>
          <fpage>1208</fpage>
          <lpage>1212</lpage>
          <pub-id pub-id-type="pmid">9849481</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0959-8049(98)00030-6</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Tannock</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Ernest</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Huan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Gemcitabine a promising new agent in the treatment of advanced urothelial cancer</article-title>
          <source>J Clin Oncol</source>
          <year>1997</year>
          <volume>15</volume>
          <fpage>3441</fpage>
          <lpage>3445</lpage>
          <pub-id pub-id-type="pmid">9396395</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figures and Tables</title>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Appearance of the metastatic swelling at the corona glandis with erythema and erosion of the glans.</p>
        </caption>
        <graphic xlink:href="1471-2407-4-90-1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Microscopic appearance of the penile lesion demonstrating a nest of atypical malignant cells (hematoxylin-eosin stain).</p>
        </caption>
        <graphic xlink:href="1471-2407-4-90-2"/>
      </fig>
    </sec>
  </back>
</article>
</pmc-articleset>
